Intervening on Opioid Use and Loneliness
Addressing Loneliness as a Therapy Target Among Individuals Using Opioids
2 other identifiers
interventional
300
1 country
1
Brief Summary
This study aims to enroll 300 participants who will be assigned to one of three 3 groups. Each group will receive an intervention lasting 6, weekly sessions of 40-60 minutes. Eligibility include having an opioid use disorder and reporting loneliness or feeling alone or disconnected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2024
CompletedFirst Posted
Study publicly available on registry
June 13, 2024
CompletedStudy Start
First participant enrolled
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
December 9, 2025
December 1, 2025
4.8 years
June 9, 2024
December 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Mean change in loneliness
Loneliness will be measured using the UCLA Loneliness Scale. A 20-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation. Participants rate each item as 1 (never), 2 (rarely), 3 (sometimes) or 4 (often). The scores range from 20-80 with higher scores indicating worse outcome.
Baseline to 6 months
Mean change in number of days of opioid use
Participants will complete a calendar indicating the type and frequency of drug use.
Baseline to 6 months
Secondary Outcomes (3)
mean change in social interactions
Baseline to 6 months
Mean change in depression
Baseline to 6 months
Mean change in anxiety
Baseline to 6 months
Study Arms (3)
Cognitive-Behavioral Therapy
EXPERIMENTALCBT delivered over the course of 6, \~45 minute sessions delivered via telehealth
therapist-delivered Health Education
ACTIVE COMPARATORHealth education sessions delivered over the course of 6, \~45 minute sessions delivered via telehealth.
self-guided Health Education
ACTIVE COMPARATORHealth education sessions that are self-guided over the course of 6 sessions
Interventions
6 sessions focused on addressing thoughts, emotions, and behaviors that maintain feeling alone as a way to reduce loneliness and substance use
Health education provides information on the importance and benefits of and guidelines for living a health lifestyle
Eligibility Criteria
You may qualify if:
- Must be 18+
- understand English -have internet access-
- screen positive for an opioid use disorder
- screen positive for elevated loneliness
You may not qualify if:
- does not understand consent
- does not have consistent access to a phone and internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- National Institute on Drug Abuse (NIDA)collaborator
- Medical University of South Carolinacollaborator
- Ohio State Universitycollaborator
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 9, 2024
First Posted
June 13, 2024
Study Start
September 19, 2024
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2029
Last Updated
December 9, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
De-identified participant data is available upon request through a data use agreement as part of scientific collaboration